Genetic shift of env V3 loop viral sequences in patients with HIV-associated neurocognitive disorder during antiretroviral therapy

Journal of NeuroVirology

Volumn 19, Issue 6, 2013, Pages 523-530

  Eggers, Christian ^a   Müller, Oliver ^b   Thordsen, Ingo ^c,e   Schreiber, Michael ^c   Methner, Axel ^d  

^a KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Austria)

^b Center for Psychiatry ^*  (Germany)

^c BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^e QIAGEN GMBH   (Germany)

Author keywords

Cellular tropism; Cerebrospinal fluid; HAND; HIV; Viral load kinetics; Viral sequences

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; LAMIVUDINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; NUCLEOSIDE ANALOG; STAVUDINE; VIRUS ENVELOPE PROTEIN; ZIDOVUDINE;

ADULT; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; FEMALE; GENE SEQUENCE; GENETIC SHIFT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LUMBAR PUNCTURE; MALE; MIDDLE AGED; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SEROCONVERSION; VIRAL CLEARANCE; VIRAL GENETICS; VIRUS GENE; VIRUS LOAD; VIRUS RESISTANCE;

ADULT; ANTI-HIV AGENTS; COGNITION DISORDERS; DRUG THERAPY, COMBINATION; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; FEMALE; GENETIC DRIFT; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RNA, VIRAL; SEVERITY OF ILLNESS INDEX; VIRAL LOAD;

EID: 84891417006     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-013-0207-5     Document Type: Article

References (28)

1. Coffin JM (1995) HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267:483-489
2. Eggers C, van Lunzen J, Buhk T, Stellbrink HJ (1999) HIV infection of the central nervous system is characterized by rapid turnover of viral RNA in the cerebrospinal fluid. J Acquir Immune Defic Syndr Hum Retrovirol 20:259-264
3. Eggers C, Hertogs K, Stuerenburg HJ, van Lunzen J, Stellbrink HJ (2003) Delayed CNS virus suppression during HAART is associated with HIV encephalopathy, but not with viral drug resistance or poor CNS drug penetration. AIDS 17:1897-1906
4. Epstein LG, Kuiken C, Blumberg BM, Hartman S, Sharer LR, Clement M, Goudsmit J (1991) HIV-1 V3 domain variation in brain and spleen of children with AIDS: tissue-specific evolution within host-determined quasispecies. Virology 180:583-590
5. Fulcher JA, Hwangbo Y, Zioni R, Nickle D, Lin X, Heath L, Mullins JI, Corey L, Zhu T (2004) Compartmentalization of HIV-1 between blood monocytes and CD4+ T cells during infection. J Virol 78:7883-7893
6. Gonzalez-Scarano F, Martin-Garcia J (2005) The neuropathogenesis of AIDS. Nat Rev Immunol 5:69-81
7. Harrington PR, Haas DW, Ritola K, Swanstrom R (2005) Compartmentalized HIV-1 present in cerebrospinal fluid is produced by short-lived cells. J Virol 79:7959-7966
8. Harrington PR, Schnell G, Letendre SL, Ritola K, Robertson K, Hall C, Burch CL, Jabara CB, Moore DT, Ellis RJ, Price RW, Swanstrom R (2009) Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course. AIDS 23:907-915
9. Hertogs K, de Bethune MP, Miller V, Ivens T, Schel P, Van Cauwenberge A, Van Den Eynde C, Van Gerwen V, Azijn H, Van Houtte M, Peeters F, Staszewski S, Conant M, Bloor S, Kemp S, Larder B, Pauwels R (1998) A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugs. Antimicrob Agents Chemother 42:269-276
10. Hoffman NG, Seillier-Moiseiwitsch F, Ahn J, Walker JM, Swanstrom R (2002) Variability in the HIV-1 gp120 Env protein linked to phenotype-associated changes in the V3 loop. J Virol 76:3852-3864
11. Keys B, Karis J, Fadeel B, Valentin A, Norkrans G, Hagberg L, Chiodi F (1993) V3 sequences of paired HIV-1 isolates from blood and cerebrospinal fluid cluster according to host and show variation related to the clinical stage of disease. Virology 196:475-483
12. Korber BT, Allen EE, Farmer AD, Myers GL (1995) Heterogeneity of HIV-1 and HIV-2. AIDS 9(Suppl A):S5-S18
13. Korber BT, Kunstman KJ, Patterson BK, Furtado M, McEvilly MM, Levy R, Wolinsky SM (1994) Genetic differences between blood- and brain-derived viral sequences from HIV-1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J Virol 68:7467-7481
14. Kumar S, Tamura K, Jakobsen IB, Nei M (2001) MEGA2: molecular evolutionary genetics analysis software. Bioinformatics 17:1244-1245
15. Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Morgello S, Simpson D, Grant I, Ellis RJ (2008) Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the CNS. Arch Neurol 65:65-70
16. Liu Y, Tang XP, McArthur JC, Scott J, Gartner S (2000) Analysis of human immunodeficiency virus type 1 gp160 sequences from a patient with HIV dementia: evidence for monocyte trafficking into brain. J Neurovirol 6(Suppl 1):S70-S81
17. Perelson AS, Essunger P, Cao Y, Vesanen M, Hurley A, Saksela K, Markowitz M, Ho DD (1997) Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387:188-191
18. Pialoux G, Fournier S, Moulignier A, Poveda JD, Clavel F, Dupont B (1997) Central nervous system as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir (letter). AIDS 11:1302-1303
19. Price RW, Brew BJ (1988) The AIDS dementia complex. Journal of Infectious Diseases 158:1079-1083
20. Ritola K, Pilcher CD, Fiscus SA, Hoffman NG, Nelson JA, Kitrinos KM, Hicks CB, Eron JJ Jr, Swanstrom R (2004) Multiple V1/V2 env variants are frequently present during primary infection with HIV-1. J Virol 78:11208-11218
21. Ritola K, Robertson K, Fiscus SA, Hall C, Swanstrom R (2005) Increased HIV-1 env compartmentalization in the presence of HIV-1-associated dementia. J Virol 79:10830-10834
22. Staprans S, Marlowe N, Glidden D, Novakovic-Agopian T, Grant RM, Heyes M, Aweeka F, Deeks S, Price RW (1999) Time course of CSF response to antiretroviral therapy: evidence for variable compartmentalization of infection. AIDS 13:1051-1061
23. Steuler H, Storch-Hagenlocher B, Wildemann B (1992) Distinct populations of HIV type 1 in blood and CSF. AIDS Res Hum Retroviruses 8:53-59
24. Strain MC, Letendre S, Pillai SK, Russell T, Ignacio CC, Gunthard HF, Good B, Smith DM, Wolinsky SM, Furtado M, Marquie-Beck J, Durelle J, Grant I, Richman DD, Marcotte T, McCutchan JA, Ellis RJ, Wong JK (2005) Genetic composition of HIV-1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. J Virol 79:1772-1788
25. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG (1997) The CLUSTAL-X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25:4876-4882
26. Wolinsky SM, Korber BT, Neumann AU, Daniels M, Kunstman KJ, Whetsell AJ, Furtado MR, Cao Y, Ho DD, Safrit JT (1996) Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 272:537-542
27. Wong JK, Ignacio CC, Torriani F, Havlir D, Fitch NJS, Richman DD (1997) In vivo compartmentalization of HIV: evidence from the examination of pol sequences from autopy tissues. J Virol 71:2059-2071
28. Zhang K, Hawken M, Rana F, Welte FJ, Gartner S, Goldsmith MA, Power C (2001) Human immunodeficiency virus type 1 clade a and d neurotropism: molecular evolution, recombination, and coreceptor use. Virology 283:19-30